CANCER RESEARCH AMERICA NFCR INC: Form 990, tax year 2018

View the entire original 990 at ProPublica ↗

Organization: CANCER RESEARCH AMERICA NFCR INC (EIN 04-2531031)
Tax period: 2018-01-01 to 2018-12-31
Filed: 2019-09-05
IRS object ID: 201902489349301250
Schema version: 2018v3.1
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule D
Schedule F
Schedule G
Schedule I
Schedule J
Schedule M
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2019-09-05T13:26:05-05:00	ReturnTs
Tax Period End	2018-12-31	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	WITHUMSMITHBROWNPC	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	4600 EAST WEST HWY 900	AddressLine1Txt
City	BETHESDA	CityNm
State Abbreviation	MD	StateAbbreviationCd
ZIP	208143423	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2018-01-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	042531031	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	NATIONAL FOUNDATION FOR CANCER RESEARCH	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
In Care Of	% KWOK LEUNG	InCareOfNm
Business Name Control	NATI	BusinessNameControlTxt
Phone	3016541250	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	5515 SECURITY LANE Suite 1105	AddressLine1Txt
City	ROCKVILLE	CityNm
State Abbreviation	MD	StateAbbreviationCd
ZIP	20852	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	SUJUAN BA	PersonNm
Person Title	PRESIDENT & CEO	PersonTitleTxt
Phone	3016541250	PhoneNum
Signature	2019-09-04	SignatureDt
Discuss With Paid Preparer	Yes (true)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	RICHARD L RUVELSON	PreparerPersonNm
PTIN	P00234075	PTIN
Phone	3012726000	PhoneNum
Preparation	2019-09-04	PreparationDt

Filing Security Information FilingSecurityInformation

IP Address IPAddress

Field	Value	IRS element (for citing)
I Pv4 Address	209.190.253.84	IPv4AddressTxt

Field	Value	IRS element (for citing)
Federal Original Submission Id	22006220192485000168	FederalOriginalSubmissionId
Federal Original Submission Id	2019-09-05	FederalOriginalSubmissionIdDt
Filing License Type	P	FilingLicenseTypeCd
At Submission Creation Device Id	833D9BA5299041826641AEDE5C1773806529F77E	AtSubmissionCreationDeviceId
At Submission Filing Device Id	EBD8DFBC700724A96E49BF1A406FB658268A8823	AtSubmissionFilingDeviceId

Field	Value	IRS element (for citing)
Tax	2018	TaxYr
Build TS	2019-02-21 02:37:17Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	SUJUAN BA	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	5515 SECURITY LANE SUITE 1105	AddressLine1Txt
City	ROCKVILLE	CityNm
State Abbreviation	MD	StateAbbreviationCd
ZIP	20852	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$14,845,391	GrossReceiptsAmt
Group Return For Affiliates	false	GroupReturnForAffiliatesInd
Group Exemption	5582	GroupExemptionNum
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	WWW.NFCR.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1973	FormationYr
Legal Domicile State	MA	LegalDomicileStateCd
Activity Or Mission	TO SUPPORT CANCER RESEARCH AND PUBLIC EDUCATION RELATING TO PREVENTION, EARLIER DIAGNOSIS, BETTER TREATMENTS AND ULTIMATELY, A CURE FOR CANCER.	ActivityOrMissionDesc
Voting Members Governing Body	8	VotingMembersGoverningBodyCnt
Voting Members Independent	8	VotingMembersIndependentCnt
Total Employee	32	TotalEmployeeCnt
Total Volunteers	100	TotalVolunteersCnt
Total Gross UBI	$7,769	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$28,717	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$11,921,451	PYContributionsGrantsAmt
CY Contributions Grants	$12,714,798	CYContributionsGrantsAmt
PY Program Service Revenue	$0	PYProgramServiceRevenueAmt
CY Program Service Revenue	$0	CYProgramServiceRevenueAmt
PY Investment Income	$740,805	PYInvestmentIncomeAmt
CY Investment Income	$724,768	CYInvestmentIncomeAmt
PY Other Revenue	$296,389	PYOtherRevenueAmt
CY Other Revenue	$257,329	CYOtherRevenueAmt
PY Total Revenue	$12,958,645	PYTotalRevenueAmt
CY Total Revenue	$13,696,895	CYTotalRevenueAmt
PY Grants And Similar Paid	$2,704,783	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$3,998,229	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$2,584,611	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$2,859,084	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$50,237	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$51,649	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$2,708,060	CYTotalFundraisingExpenseAmt
PY Other Expenses	$8,092,769	PYOtherExpensesAmt
CY Other Expenses	$8,238,769	CYOtherExpensesAmt
PY Total Expenses	$13,432,400	PYTotalExpensesAmt
CY Total Expenses	$15,147,731	CYTotalExpensesAmt
PY Revenues Less Expenses	-$473,755	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	-$1,450,836	CYRevenuesLessExpensesAmt
Total Assets BOY	$14,949,937	TotalAssetsBOYAmt
Total Assets EOY	$13,294,160	TotalAssetsEOYAmt
Total Liabilities BOY	$2,043,145	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$2,997,583	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$12,906,792	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$10,296,577	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	SEE SCHEDULE O	MissionDesc
Significant New Program Srvc	false	SignificantNewProgramSrvcInd
Significant Change	false	SignificantChangeInd
Expense	$5,627,446	ExpenseAmt
Grant	$3,998,229	GrantAmt
Desc	CANCER RESEARCH - SEE SCHEDULE O	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$5,563,306	ExpenseAmt
Desc	CANCER PREVENTION EDUCATION TO THE PUBLIC - SEE SCHEDULE O	Desc

Field	Value	IRS element (for citing)
Total Program Service Expenses	$11,190,752	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (true)	DescribedInSection501c3Ind
Schedule B Required	Yes (true)	ScheduleBRequiredInd
Political Campaign Acty	false	PoliticalCampaignActyInd
Lobbying Activities	false	LobbyingActivitiesInd
Subject To Proxy Tax	false	SubjectToProxyTaxInd
Donor Advised Fund	Yes (true)	DonorAdvisedFundInd
Conservation Easements	false	ConservationEasementsInd
Collections Of Art	false	CollectionsOfArtInd
Credit Counseling	false	CreditCounselingInd
Temp Or Permanent Endowments	Yes (true)	TempOrPermanentEndowmentsInd
Report Land Building Equipment	Yes (true)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	false	ReportInvestmentsOtherSecInd
Report Program Related Invst	false	ReportProgramRelatedInvstInd
Report Other Assets	Yes (true)	ReportOtherAssetsInd
Report Other Liabilities	Yes (true)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (true)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	false	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (true)	ConsolidatedAuditFinclStmtInd
School Operating	false	SchoolOperatingInd
Foreign Office	false	ForeignOfficeInd
Foreign Activities	false	ForeignActivitiesInd
More Than5000 K To Org	false	MoreThan5000KToOrgInd
More Than5000 K To Individuals	Yes (true)	MoreThan5000KToIndividualsInd
Professional Fundraising	Yes (true)	ProfessionalFundraisingInd
Fundraising Activities	Yes (true)	FundraisingActivitiesInd
Gaming Activities	false	GamingActivitiesInd
Operate Hospital	false	OperateHospitalInd
Grants To Organizations	Yes (true)	GrantsToOrganizationsInd
Grants To Individuals	Yes (true)	GrantsToIndividualsInd
Schedule J Required	Yes (true)	ScheduleJRequiredInd
Tax Exempt Bonds	false	TaxExemptBondsInd
Engaged In Excess Benefit Trans	false	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	false	PYExcessBenefitTransInd
Loan Outstanding	false	LoanOutstandingInd
Grant To Related Person	false	GrantToRelatedPersonInd
Business Rln With Org Mem	false	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	false	BusinessRlnWithFamMemInd
Business Rln With Officer Ent	false	BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri	Yes (true)	DeductibleNonCashContriInd
Deductible Art Contribution	false	DeductibleArtContributionInd
Terminate Operations	false	TerminateOperationsInd
Partial Liquidation	false	PartialLiquidationInd
Disregarded Entity	false	DisregardedEntityInd
Related Entity	Yes (true)	RelatedEntityInd
Related Organization Ctrl Ent	false	RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	false	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	false	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (true)	ScheduleORequiredInd
IRP Document	30	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (true)	BackupWthldComplianceInd
Employee	32	EmployeeCnt
Employment Tax Returns Filed	Yes (true)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	Yes (true)	UnrelatedBusIncmOverLimitInd
Form990 T Filed	Yes (true)	Form990TFiledInd
Foreign Financial Account	Yes (true)	ForeignFinancialAccountInd
Foreign Country	HK	ForeignCountryCd
Prohibited Tax Shelter Trans	false	ProhibitedTaxShelterTransInd
Taxable Party Notification	false	TaxablePartyNotificationInd
Nondeductible Contributions	false	NondeductibleContributionsInd
Quid Pro Quo Contributions	Yes (true)	QuidProQuoContributionsInd
Quid Pro Quo Contri Discl	Yes (true)	QuidProQuoContriDisclInd
Form8282 Property Disposed Of	false	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	false	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	false	PayPremiumsPrsnlBnftCntrctInd
DAF Excess Business Holdings	false	DAFExcessBusinessHoldingsInd
Taxable Distributions	false	TaxableDistributionsInd
Distribution To Donor	false	DistributionToDonorInd
Indoor Tanning Services	false	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	false	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	false	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	8	GoverningBodyVotingMembersCnt
Independent Voting Member	8	IndependentVotingMemberCnt
Family Or Business Rln	Yes (true)	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	false	DelegationOfMgmtDutiesInd
Change To Org Documents	false	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	false	MaterialDiversionOrMisuseInd
Members Or Stockholders	false	MembersOrStockholdersInd
Election Of Board Members	false	ElectionOfBoardMembersInd
Decisions Subject To Approva	false	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (true)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (true)	MinutesOfCommitteesInd
Officer Mailing Address	false	OfficerMailingAddressInd
Local Chapters	Yes (true)	LocalChaptersInd
Policies Reference Chapters	Yes (true)	PoliciesReferenceChaptersInd
Form990 Provided To Gvrn Body	Yes (true)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (true)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (true)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (true)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (true)	WhistleblowerPolicyInd
Document Retention Policy	Yes (true)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (true)	CompensationProcessCEOInd
Compensation Process Other	Yes (true)	CompensationProcessOtherInd
Investment In Joint Venture	false	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AZ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	DC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	GA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	HI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ME	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NM	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ND	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	RI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WV	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
Own Website	Yes (X)	OwnWebsiteInd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	KWOK LEUNG	PersonNm
Phone	3016541250	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	5515 SECURITY LANE SUITE 1105	AddressLine1Txt
City	ROCKVILLE	CityNm
State Abbreviation	MD	StateAbbreviationCd
ZIP	20852	ZIPCd

Field	Value	IRS element (for citing)
Info In Schedule O Part VII	Yes (X)	InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (14 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Highest Compensated EmployeeHighestCompensatedEmployeeInd
JOSEPH F FRANLIN
CHAIR	10.0	0.0	Yes (X)	Yes (X)	$0	$0	$0
WENDI P DENNARD
TREASURER	2.0	0.0	Yes (X)	Yes (X)	$0	$0	$0
JUDITH P BARNHARD
DIRECTOR	2.0	0.0	Yes (X)		$0	$0	$0
MICHAEL BURKE
DIRECTOR	2.0	0.0	Yes (X)		$0	$0	$0
PADMAKUMAR KAIMAL
DIRECTOR	2.0	0.0	Yes (X)		$0	$0	$0
GUS KODERSHA
DIRECTOR (AS OF 5/2018)	2.0	0.0	Yes (X)		$0	$0	$0
WILLIAM SCANDONE
DIRECTOR (AS OF 5/2018)	2.0	0.0	Yes (X)		$0	$0	$0
EDWARD S WEST
DIRECTOR	2.0	0.0	Yes (X)		$0	$0	$0
FRANKLIN C SALISBURY JR
CHIEF EXECUTIVE OFFICER	40.0	2.0		Yes (X)	$309,915	$0	$71,685
SUJUAN BA
PRESIDENT/COO	40.0	5.0		Yes (X)	$318,810	$0	$72,099
KWOK LEUNG
CFO/SECRETARY	40.0	5.0		Yes (X)	$179,493	$0	$28,603
YI WANG
CHIEF STRTGY OFF. - ALLIANCES	40.0	1.0			$202,005	$0	$32,493	Yes (X)
BRIAN WACHTEL
SR. DIR. PARTNERSHIPS & EVENTS	40.0	0.0			$109,178	$0	$13,972	Yes (X)
BRADLEY GILLENWATER
SR. DIR. COMMUNICATIONS	40.0	2.0			$108,907	$0	$12,886	Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$1,228,308	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$231,738	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	6	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	false	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (true)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	false	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
REDFIELD DIRECT LLC
11422 MIRACLE HILLS DR 450	OMAHA	NE	68154	LABEL PRINTING	$1,026,067
CALMARK GROUP LLC
6755 S SAYRE AVE	BEDFORD PARK	IL	60638	MAILSHOP	$776,111
CP DIRECT INC
4600 A BOSTON WAY	LANHAM	MD	20706	PRINTING	$624,044
KEY ACQUISITION PARTNERS
181 HARRY S TRUMAN PKWY 265	ANNAPOLIS	MD	21401	LIST BROKER	$536,661
MACKAY MITCHELL ENVELOPE CO
2100 ELM ST SE	MINNEAPOLIS	MN	55414	ENVELOPE PRINTING	$452,567

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	9	CntrctRcvdGreaterThan100KCnt
Federated Campaigns	$59,730	FederatedCampaignsAmt
Fundraising	$351,748	FundraisingAmt
All Other Contributions	$12,303,320	AllOtherContributionsAmt
Noncash Contributions	$253,295	NoncashContributionsAmt
Total Contributions	$12,714,798	TotalContributionsAmt
Total Program Service Revenue	$0	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$293,923	TotalRevenueColumnAmt
Exclusion	$293,923	ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$14,936	TotalRevenueColumnAmt
Exclusion	$14,936	ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	$0	RealAmt
Personal	$0	PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$1,517,019	SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$1,086,174	SecuritiesAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$430,845	SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$430,845	TotalRevenueColumnAmt
Exclusion	$430,845	ExclusionAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$36,978	FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event	$351,748	ContriRptFundraisingEventAmt
Fundraising Direct Expenses	$62,322	FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	-$25,344	TotalRevenueColumnAmt
Exclusion	-$25,344	ExclusionAmt

Field	Value	IRS element (for citing)
Gaming Gross Income	$0	GamingGrossIncomeAmt
Gaming Direct Expenses	$0	GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Field	Value	IRS element (for citing)
Gross Sales Of Inventory	$0	GrossSalesOfInventoryAmt
Cost Of Goods Sold	$0	CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp

Field	Value	IRS element (for citing)
Desc	MAILING LIST RENTALS	Desc
Business	541800	BusinessCd
Total Revenue Column	$267,737	TotalRevenueColumnAmt
Unrelated Business Revenue	$7,769	UnrelatedBusinessRevenueAmt
Exclusion	$259,968	ExclusionAmt

Field	Value	IRS element (for citing)
Other Revenue Total	$267,737	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$13,696,895	TotalRevenueColumnAmt
Unrelated Business Revenue	$7,769	UnrelatedBusinessRevenueAmt
Exclusion	$974,328	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$3,784,543	TotalAmt
Program Services	$3,784,543	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$203,686	TotalAmt
Program Services	$203,686	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$10,000	TotalAmt
Program Services	$10,000	ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$980,605	TotalAmt
Program Services	$798,678	ProgramServicesAmt
Management And General	$174,202	ManagementAndGeneralAmt
Fundraising	$7,725	FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$1,519,461	TotalAmt
Program Services	$1,073,867	ProgramServicesAmt
Management And General	$222,441	ManagementAndGeneralAmt
Fundraising	$223,153	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$109,055	TotalAmt
Program Services	$70,060	ProgramServicesAmt
Management And General	$16,269	ManagementAndGeneralAmt
Fundraising	$22,726	FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$95,110	TotalAmt
Program Services	$50,993	ProgramServicesAmt
Management And General	$32,674	ManagementAndGeneralAmt
Fundraising	$11,443	FundraisingAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$154,853	TotalAmt
Program Services	$114,924	ProgramServicesAmt
Management And General	$24,735	ManagementAndGeneralAmt
Fundraising	$15,194	FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$134,004	TotalAmt
Program Services	$11,111	ProgramServicesAmt
Management And General	$122,893	ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$42,520	TotalAmt
Management And General	$42,520	ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$51,649	TotalAmt
Fundraising	$51,649	FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$65,816	TotalAmt
Management And General	$65,816	ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$249,537	TotalAmt
Program Services	$107,244	ProgramServicesAmt
Management And General	$142,293	ManagementAndGeneralAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$129,253	TotalAmt
Management And General	$128,810	ManagementAndGeneralAmt
Fundraising	$443	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$294,652	TotalAmt
Program Services	$84,901	ProgramServicesAmt
Management And General	$188,930	ManagementAndGeneralAmt
Fundraising	$20,821	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$421,220	TotalAmt
Program Services	$290,449	ProgramServicesAmt
Management And General	$4,014	ManagementAndGeneralAmt
Fundraising	$126,757	FundraisingAmt

Royalties RoyaltiesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$243,669	TotalAmt
Program Services	$182,012	ProgramServicesAmt
Management And General	$37,618	ManagementAndGeneralAmt
Fundraising	$24,039	FundraisingAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$47,935	TotalAmt
Program Services	$19,546	ProgramServicesAmt
Management And General	$28,389	ManagementAndGeneralAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$69,877	TotalAmt
Program Services	$69,877	ProgramServicesAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$35,941	TotalAmt
Program Services	$26,661	ProgramServicesAmt
Management And General	$5,753	ManagementAndGeneralAmt
Fundraising	$3,527	FundraisingAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$38,649	TotalAmt
Program Services	$28,657	ProgramServicesAmt
Management And General	$6,183	ManagementAndGeneralAmt
Fundraising	$3,809	FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	FundraisingFundraisingAmt	Management And GeneralManagementAndGeneralAmt
DIRECT MAIL PROGRAMS	$6,268,258	$4,146,956	$2,121,302
LOCK BOX SERVICE	$121,989	$82,068	$39,921
PROCESS FEES-LIST SALES	$51,046	$34,519	$16,527
MAJOR GIFT	$19,832		$19,024	$808

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$4,571	TotalAmt
Management And General	$4,571	ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$15,147,731	TotalAmt
Program Services	$11,190,752	ProgramServicesAmt
Management And General	$1,248,919	ManagementAndGeneralAmt
Fundraising	$2,708,060	FundraisingAmt

Field	Value	IRS element (for citing)
Joint Costs	Yes (X)	JointCostsInd

Total Joint Costs TotalJointCostsGrp

Field	Value	IRS element (for citing)
Total	$6,740,146	TotalAmt
Program Services	$4,664,361	ProgramServicesAmt
Fundraising	$2,075,785	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$1,000	BOYAmt
EOY	$1,000	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$2,565,486	BOYAmt
EOY	$1,167,990	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$119,157	BOYAmt
EOY	$106,247	EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$424,444	BOYAmt
EOY	$583,645	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$387,823	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$250,006	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$123,318	BOYAmt
EOY	$137,817	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$9,104,342	BOYAmt
EOY	$7,370,729	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$442	BOYAmt
EOY	$442	EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$2,611,748	BOYAmt
EOY	$3,926,290	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$14,949,937	BOYAmt
EOY	$13,294,160	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$2,034,818	BOYAmt
EOY	$1,311,474	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$8,327	BOYAmt
EOY	$135	EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$1,685,974	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$2,043,145	BOYAmt
EOY	$2,997,583	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows SFAS117	Yes (X)	OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$9,308,044	BOYAmt
EOY	$7,141,083	EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$1,433,990	BOYAmt
EOY	$1,213,987	EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$2,164,758	BOYAmt
EOY	$1,941,507	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$12,906,792	BOYAmt
EOY	$10,296,577	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$14,949,937	BOYAmt
EOY	$13,294,160	EOYAmt

Field	Value	IRS element (for citing)
Reconcilation Revenue Expnss	-$1,450,836	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	-$1,159,379	NetUnrlzdGainsLossesInvstAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	false	AccountantCompileOrReviewInd
FS Audited	Yes (true)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consolidated Basis Fincl Stmt	Yes (X)	ConsolidatedBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (true)	AuditCommitteeInd
Federal Grant Audit Required	false	FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$14,884,024	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$13,729,474	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$13,952,247	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$11,921,451	CurrentTaxYearMinus1YearAmt
Current Tax Year	$12,714,798	CurrentTaxYearAmt
Total	$67,201,994	TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$14,884,024	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$13,729,474	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$13,952,247	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$11,921,451	CurrentTaxYearMinus1YearAmt
Current Tax Year	$12,714,798	CurrentTaxYearAmt
Total	$67,201,994	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$0	SubstantialContributorsTotAmt
Public Support Total170	$67,201,994	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$334,775	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$372,780	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$287,499	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$296,562	CurrentTaxYearMinus1YearAmt
Current Tax Year	$308,859	CurrentTaxYearAmt
Total	$1,600,475	TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$7,420	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$16,841	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$9,182	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$647	CurrentTaxYearMinus1YearAmt
Total	$34,090	TotalAmt

Other Income170 OtherIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$363,577	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$341,191	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$348,604	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$284,518	CurrentTaxYearMinus1YearAmt
Current Tax Year	$259,968	CurrentTaxYearAmt
Total	$1,597,858	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$70,434,417	TotalSupportAmt
Public Support CY170	0.95411	PublicSupportCY170Pct
Public Support PY170	0.94651	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Donor Advised Funds Held	1	DonorAdvisedFundsHeldCnt
Donor Advised Funds Contri	$0	DonorAdvisedFundsContriAmt
Donor Advised Funds Grants	$0	DonorAdvisedFundsGrantsAmt
Donor Advised Funds Vl EOY	$3,040	DonorAdvisedFundsVlEOYAmt
Disclosed Org Leg Ctrl	Yes (true)	DisclosedOrgLegCtrlInd
Disclosed For Charitable Prps	Yes (true)	DisclosedForCharitablePrpsInd
Art Public Exhibition Amounts		ArtPublicExhibitionAmountsGrp
Held Works Art		HeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$8,699,102	BeginningYearBalanceAmt
Contributions	$7,119,860	ContributionsAmt
Investment Earnings Or Losses	-$271,815	InvestmentEarningsOrLossesAmt
Other Expenditures	$5,150,164	OtherExpendituresAmt
End Year Balance	$10,396,983	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$8,164,316	BeginningYearBalanceAmt
Contributions	$3,394,266	ContributionsAmt
Investment Earnings Or Losses	$213,282	InvestmentEarningsOrLossesAmt
Other Expenditures	$3,072,762	OtherExpendituresAmt
End Year Balance	$8,699,102	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,627,682	BeginningYearBalanceAmt
Contributions	$3,687,809	ContributionsAmt
Investment Earnings Or Losses	$22,308	InvestmentEarningsOrLossesAmt
Other Expenditures	$3,173,483	OtherExpendituresAmt
End Year Balance	$8,164,316	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,771,063	BeginningYearBalanceAmt
Contributions	$3,491,261	ContributionsAmt
Investment Earnings Or Losses	-$158,768	InvestmentEarningsOrLossesAmt
Other Expenditures	$3,475,874	OtherExpendituresAmt
End Year Balance	$7,627,682	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,621,530	BeginningYearBalanceAmt
Contributions	$3,324,595	ContributionsAmt
Investment Earnings Or Losses	$142,232	InvestmentEarningsOrLossesAmt
Other Expenditures	$3,317,294	OtherExpendituresAmt
End Year Balance	$7,771,063	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Board Designated Balance EOY	0.67860	BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY	0.18670	PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY	0.13470	TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org	false	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	false	EndowmentsHeldRelatedOrgInd
Land		LandGrp
Buildings		BuildingsGrp

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$26,890	OtherCostOrOtherBasisAmt
Depreciation	$2,739	DepreciationAmt
Book Value	$24,151	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$360,933	OtherCostOrOtherBasisAmt
Depreciation	$247,267	DepreciationAmt
Book Value	$113,666	BookValueAmt

Field	Value	IRS element (for citing)
Other Land Buildings		OtherLandBuildingsGrp
Total Book Value Land Buildings	$137,817	TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp (2 entries)

DescDesc	Book ValueBookValueAmt
AMOUNT HELD IN TRUST BY OTHERS	$2,339,933
RIGHT OF USE ASSET	$1,586,357

Field	Value	IRS element (for citing)
Total Book Value Other Assets	$3,926,290	TotalBookValueOtherAssetsAmt
Federal Income Tax Liability	$0	FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

Field	Value	IRS element (for citing)
Desc	LEASE LIABILITY	Desc
Amt	$1,685,974	Amt

Field	Value	IRS element (for citing)
Total Liability	$1,685,974	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd
Total Rev Etc Audited Fincl Stmt	$12,594,665	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	-$1,159,379	NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts	$20,000	DonatedServicesAndUseFcltsAmt
Other Revenue	$111,000	OtherRevenueAmt
Revenue Not Reported	-$1,028,379	RevenueNotReportedAmt
Revenue Subtotal	$13,623,044	RevenueSubtotalAmt
Investment Expenses Not Incld	$65,816	InvestmentExpensesNotIncldAmt
Other Revenues Not Included	$8,035	OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt	$73,851	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$13,696,895	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$15,436,106	TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts	$20,000	DonatedServicesUseFcltsAmt
Other Expenses Included	$342,226	OtherExpensesIncludedAmt
Expenses Not Reported	$362,226	ExpensesNotReportedAmt
Expenses Subtotal	$15,073,880	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$65,816	InvestmentExpensesNotIncld2Amt
Other Expenses Not Included	$8,035	OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt	$73,851	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$15,147,731	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART V, LINE 4 - INTENDED USE OF ENDOWMENT FUNDS:	THE PRINCIPAL ACTIVITIES OF NFCR ARE RAISING FUNDS AND FIGHTING CANCER THROUGH RESEARCH IN PREVENTION, EARLIER DIAGNOSTIC TECHNIQUES, MORE EFFECTIVE TREATMENTS AND ULTIMATELY, ACHIEVING ONE OF MEDICINES GREATEST GOALS: CURING CANCER TO SAVE LIVES. THE FOUNDATION FULFILLS THIS MISSION BY FUNDING ACROSS THE WORLD OUTSTANDING SCIENTISTS THAT PIONEER CANCER RESEARCH AND FUNDING CANCER PREVENTION EDUCATION PROGRAMS. THE DESIGNATED NET ASSETS, TEMPORARILY RESTRICTED NET ASSETS, AND PERMANENTLY RESTRICTED NET ASSETS ALL ARE INTENDED TO PROVIDE FUNDING FOR SUCH RESEARCH AND EDUCATION PROGRAMS.
PART X, LINE 2 - FIN 48 FOOTNOTE:	ACCOUNTING PRINCIPLES GENERALLY ACCEPTED IN THE UNITED STATES OF AMERICA REQUIRE MANAGEMENT TO EVALUATE INCOME TAX POSITIONS TAKEN AND ACCRUE AN INCOME TAX LIABILITY IF THE ORGANIZATION HAS TAKEN AN UNCERTAIN POSITION THAT MORE LIKELY THAN NOT WOULD NOT BE SUSTAINED UPON EXAMINATION BY TEH INTERNAL REVENUE SERVICE. MANAGEMENT HAS EVALUATED THE INCOME TAX POSITIONS TAKEN AND CONCLUDED THAT AS OF DECEMBER 31, 2018 THERE ARE NO UNCERTAIN POSITIONS TAKEN OR EXPECTED TO BE TAKEN THAT WOULD REQUIRE RECOGNITION IN THE CONSOLIDATED FINANCIAL STATEMENTS. THE NJCR AND AFFILIATES ARE SUBJECT TO ROUTINE AUDITS BY TAXING JURISDICTIONS; HOWEVER, THERE ARE CURRENTLY NO AUDITS IN PROGRESS FOR ANY TAX PERIODS. IN ADDITION, THERE HAVE BEEN NO TAX RELATED INTEREST OR PENALTIES FOR THE PERIOD PRESENTED IN THESE FINANCIAL STATEMENTS. SHOULD SUCH PENALTIES AND INTEREST BE INCURRED, THE FOUNDATION'S POLICY IS TO RECOGNIZE THEM AS GENERAL AND ADMINISTRATIVE EXPENSES ON THE STATEMENT OF ACTIVITIES.
PART XI, LINE 2D - OTHER REVENUES INCLUDED ON FINANCIALS, NOT FORM 990:	$111,000 - RELATED ORGANIZATIONS' REVENUES
PART XI, LINE 4B - OTHER	$8,035 - FOREIGN TAXES WITHHOLDING ON INVESTMENT INCOME DEDUCTED FROM REVENUES ON FINANCIAL STATEMENTS
PART XII, LINE 2D - OTHER EXPENSES INCLUDED ON FINANCIALS, NOT FORM 990:	$342,226 - RELATED ORGANIZATIONS' EXPENSES
PART XII, LINE 4B - OTHER	$8,035 - FOREIGN TAXES WITHHOLDING ON INVESTMENT INCOME DEDUCTED FROM REVENUES ON FINANCIAL STATEMENTS

Schedule F IRS990ScheduleF

Foreign Individuals Grants ForeignIndividualsGrantsGrp (2 entries)

Type Of AssistanceTypeOfAssistanceTxt	RegionRegionTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt
RESEARCH REVIEW	Europe (Including Iceland and Greenland)	1	$5,000	CHECK
RESEARCH REVIEW	East Asia and the Pacific	1	$5,000	CHECK

Field	Value	IRS element (for citing)
Transfer To Foreign Corp	false	TransferToForeignCorpInd
Interest In Foreign Trust	false	InterestInForeignTrustInd
Foreign Corp Ownership	false	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	false	PassiveForeignInvestmestCoInd
Foreign Partnership	false	ForeignPartnershipInd
Boycott Countries	false	BoycottCountriesInd

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	Yes (X)	MailSolicitationsInd
Email Solicitations	Yes (X)	EmailSolicitationsInd
Phone Solicitations	Yes (X)	PhoneSolicitationsInd
In Person Solicitations	Yes (X)	InPersonSolicitationsInd
Solicitation Of Non Govt Grants	Yes (X)	SolicitationOfNonGovtGrantsInd
Special Fundraising Events	Yes (X)	SpecialFundraisingEventsInd
Agrmt Prof Fundraising Acty	Yes (true)	AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp

Field	Value	IRS element (for citing)
Person	MERKLE INC	PersonNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	7001 COLUMBIA GATEWAY DRIVE	AddressLine1Txt
City	COLUMBIA	CityNm
State Abbreviation	MD	StateAbbreviationCd
ZIP	21046	ZIPCd

Field	Value	IRS element (for citing)
Activity	DIRECT MAIL COUNSEL	ActivityTxt
Fundraiser Control Of Funds	false	FundraiserControlOfFundsInd
Gross Receipts	$6,514,714	GrossReceiptsAmt
Retained By Contractor	$51,649	RetainedByContractorAmt
Net To Organization	$6,463,065	NetToOrganizationAmt

Field	Value	IRS element (for citing)
Total Gross Receipts	$6,514,714	TotalGrossReceiptsAmt
Total Retained By Contractors	$51,649	TotalRetainedByContractorsAmt
Total Net To Organization	$6,463,065	TotalNetToOrganizationAmt
Licensed States	AL	LicensedStatesCd
Licensed States	AK	LicensedStatesCd
Licensed States	AZ	LicensedStatesCd
Licensed States	AR	LicensedStatesCd
Licensed States	CA	LicensedStatesCd
Licensed States	CO	LicensedStatesCd
Licensed States	CT	LicensedStatesCd
Licensed States	DC	LicensedStatesCd
Licensed States	FL	LicensedStatesCd
Licensed States	GA	LicensedStatesCd
Licensed States	HI	LicensedStatesCd
Licensed States	IL	LicensedStatesCd
Licensed States	IN	LicensedStatesCd
Licensed States	KS	LicensedStatesCd
Licensed States	KY	LicensedStatesCd
Licensed States	ME	LicensedStatesCd
Licensed States	MD	LicensedStatesCd
Licensed States	MA	LicensedStatesCd
Licensed States	MI	LicensedStatesCd
Licensed States	MN	LicensedStatesCd
Licensed States	MO	LicensedStatesCd
Licensed States	NH	LicensedStatesCd
Licensed States	NJ	LicensedStatesCd
Licensed States	NM	LicensedStatesCd
Licensed States	NY	LicensedStatesCd
Licensed States	NC	LicensedStatesCd
Licensed States	ND	LicensedStatesCd
Licensed States	OH	LicensedStatesCd
Licensed States	OK	LicensedStatesCd
Licensed States	OR	LicensedStatesCd
Licensed States	PA	LicensedStatesCd
Licensed States	RI	LicensedStatesCd
Licensed States	SC	LicensedStatesCd
Licensed States	TN	LicensedStatesCd
Licensed States	UT	LicensedStatesCd
Licensed States	VA	LicensedStatesCd
Licensed States	WA	LicensedStatesCd
Licensed States	WV	LicensedStatesCd
Licensed States	WY	LicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

Field	Value	IRS element (for citing)
Event1	DAFFODILS	Event1Nm
Gross Receipts Event1	$123,259	GrossReceiptsEvent1Amt
Charitable Contri Event1	$86,281	CharitableContriEvent1Amt
Gross Revenue Event1	$36,978	GrossRevenueEvent1Amt
Food And Beverage Event1	$19,437	FoodAndBeverageEvent1Amt
Entertainment Event1	$3,920	EntertainmentEvent1Amt
Other Direct Expenses Event1	$1,889	OtherDirectExpensesEvent1Amt
Event2	PLAY 4 THE CURE	Event2Nm
Gross Receipts Event2	$211,207	GrossReceiptsEvent2Amt
Charitable Contri Event2	$211,207	CharitableContriEvent2Amt
Other Direct Expenses Event2	$21,408	OtherDirectExpensesEvent2Amt
Other Events Total	50	OtherEventsTotalCnt
Gross Receipts Other Events	$54,260	GrossReceiptsOtherEventsAmt
Charitable Contri Other Events	$54,260	CharitableContriOtherEventsAmt
Oth Direct Expnss Other Events	$15,668	OthDirectExpnssOtherEventsAmt
Gross Receipts Total	$388,726	GrossReceiptsTotalAmt
Charitable Contributions Tot	$351,748	CharitableContributionsTotAmt
Gross Revenue Total Events	$36,978	GrossRevenueTotalEventsAmt
Food And Beverage Total Events	$19,437	FoodAndBeverageTotalEventsAmt
Entertainment Total Events	$3,920	EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events	$38,965	OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events	$62,322	DirectExpenseSummaryEventsAmt
Net Income Summary	-$25,344	NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (23 entries)

Address Line1USAddress/AddressLine1Txt	Address Line2USAddress/AddressLine2Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt	Non Cash AssistanceNonCashAssistanceAmt	Valuation Method UsedValuationMethodUsedDesc	Non Cash AssistanceNonCashAssistanceDesc
THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
445 NORTH FIFTH ST	SUITE 600	PHOENIX	AZ	85004	753065445	501(c)(3)	$98,413	RESEARCH CONTRACTS
ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRIS PARK AVE		BRONX	NY	10461	472209056	501(c)(3)	$93,652	RESEARCH CONTRACTS	$47,159	FMV	CHEMICALS & MATERIAL
CASE WESTERN RESERVE UNIVERSITY
10900 EUCLID AVENUE		CLEVELAND	OH	44106	341018992	501(c)(3)	$86,437	RESEARCH CONTRACTS
DANA-FARBER CANCER INSTITUTE
44 BINNEY ST	MAIL STOP L229	BOSTON	MA	02115	042263040	501(c)(3)	$100,000	RESEARCH CONTRACTS
MASSACHUSETTS GENERAL HOSPITAL
PO BOX 414876		BOSTON	MA	02241	041564655	501(c)(3)	$312,790	RESEARCH CONTRACTS	$44,987	FMV	CHEMICALS & MATERIAL
THE SCRIPPS RESEARCH INSTITUTE
10550 N TORREY PINES RD		LA JOLLA	CA	92037	330435954	501(c)(3)	$100,000	RESEARCH CONTRACTS
UNIVERSITY OF TEXAS - MD ANDERSON CANCER CENTER
PO BOX 4390		HOUSTON	TX	77210	746001118	501(c)(3)	$39,889	RESEARCH CONTRACTS
UNIVERSITY OF MARYLAND
220 ARCH ST	OFFICE LEVEL 2	BALTIMORE	MD	21201	526002033	501(c)(3)	$100,000	RESEARCH CONTRACTS
VIRGINIA COMMONWEALTH UNIVERSITY
PO BOX 980568		RICHMOND	VA	23298	546001758	501(C)(3)	$100,000	RESEARCH CONTRACTS	$20,000	FMV	CHEMICALS & MATERIAL
KUMC RESEARCH INSTITUTE INC
3901 RAINBOW BLVD	MAIL STOP 1039	KANSAS CITY	KS	66103	481108830	501(c)(3)	$86,242	RESEARCH CONTRACTS
UNIVERSITY OF PENNSYLVANIA
3451 WALNUT ST		PHILADELPHIA	PA	19104	231352685	501(C)(3)	$100,000	RESEARCH CONTRACTS	$15,000	FMV	CHEMICALS & MATERIAL
SCOTTSDALE HEALTHCARE CORP
8125 N HAYDEN RD		SCOTTSDALE	AZ	85258	942735850	501(C)(3)	$87,800	CANCER HOTLINE
WAKE FOREST UNIVERSITY HEALTH SCIENCES
MEDICAL CENTER BLVD		WINSTONSALEM	NC	27157	223849199	501(C)(3)	$113,645	RESEARCH CONTRACTS	$20,000	FMV	CHEMICALS & MATERIAL
INVAMET THERAPEUTICS LLC
251 LITTLE FALLS DRIVE		WILMINGTON	DE	19808	821967545		$225,000	TRANSLATIONAL
NONPARIEL BIOTECHNOLOGIES LLC
2010 CORPORATE RIDGE		MCLEAN	VA	22102	475684209		$125,000	TRANSLATIONAL
ONCOKIDS BIOSCIENCES
43 KENT ST 1		BROOKLINE	MA	02445	823410836		$100,000	TRANSLATIONAL
STROMATIS PHARMA LLC
225 GARLAND HILL DR		ATHENS	GA	30605	822219124		$125,000	TRANSLATIONAL
INTERLEUKIN COMBINATORIAL THERAPIES INC
251 LITTLE FALLS DRIVE		WILMINGTON	DE	19808	823395941		$200,000	TRANSLATIONAL
GLOBAL COALITION FOR ADAPTIVE RESEARCH INC
PO BOX 427		LEXINGTON	MA	02420	821199380	501(C)(3)	$562,688	RESEARCH CONTRACTS
SILCSBIO LLC
8 MARKET PLACE 300		BALTIMORE	MD	21230	455174923		$100,000	TRANSLATIONAL
TVARDI THERAPEUTICS INC
7000 FANNIN STREET 1960M		HOUSTON	TX	77030	823784554		$500,000	TRANSLATIONAL
YIVIVA INC
447 BROADWAY 2F		NEW YORK	NY	10013	811602368		$100,000	TRANSLATIONAL
VITANOVA BIOMEDICAL INC
222 SID BAKER ST 365		KERRVILLE	TX	78028	471205206		$25,000	TRANSLATIONAL

Field	Value	IRS element (for citing)
Total501c3 Org	14	Total501c3OrgCnt
Total Other Org	9	TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (4 entries)

Grant TypeGrantTypeTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt
CANCER RESEARCH	4	$111,029
RESEARCH REVIEW	4	$65,000
CANCER RESEARCH REWARD	2	$25,000
TRAVEL FOR CANCER RESEARCH EVENT	5	$2,657

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2 - PROCEDURES FOR MONITORING USE OF GRANT FUNDS IN USA:	FormAndLineReferenceDesc
Explanation	GRANT AND CONTRACT RECIPIENTS ARE REQUIRED TO SUBMIT QUARTERLY EXPENDITURE REPORTS AND ANNUAL PROGRESS REPORTS TO NFCR.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Form990 Of Other Organizations	Yes (X)	Form990OfOtherOrganizationsInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	false	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	false	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	false	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	false	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	false	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	false	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	false	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	false	AnyNonFixedPaymentsInd
Initial Contract Exception	false	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (4 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
FRANKLIN C SALISBURY JR
CHIEF EXECUTIVE OFFICER	$308,727	$0	$0	$1,188	$53,000	$0	$18,685	$0	$381,600	$0	$0	$0
SUJUAN BA
PRESIDENT/COO	$318,036	$0	$0	$774	$53,000	$0	$19,099	$0	$390,909	$0	$0	$0
KWOK LEUNG
CFO/SECRETARY	$178,719	$0	$0	$774	$26,808	$0	$1,795	$0	$208,096	$0	$0	$0
YI WANG
CHIEF STRTGY OFF. - ALLIANCES	$200,817	$0	$0	$1,188	$30,178	$0	$2,315	$0	$234,498	$0	$0	$0

Schedule M IRS990ScheduleM

Field	Value	IRS element (for citing)
Works Of Art		WorksOfArtGrp
Art Historical Treasures		ArtHistoricalTreasuresGrp
Art Fractional Interest		ArtFractionalInterestGrp
Books And Publications		BooksAndPublicationsGrp
Clothing And Household Goods		ClothingAndHouseholdGoodsGrp
Cars And Other Vehicles		CarsAndOtherVehiclesGrp
Boats And Planes		BoatsAndPlanesGrp
Intellectual Property		IntellectualPropertyGrp

Securities Publicly Traded SecuritiesPubliclyTradedGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	13	ContributionCnt
Noncash Contributions Rpt F990	$106,151	NoncashContributionsRptF990Amt
Method Of Determining Revenues	stock market value	MethodOfDeterminingRevenuesTxt

Field	Value	IRS element (for citing)
Securities Closely Held Stock		SecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust Intrsts		SecurPrtnrshpTrustIntrstsGrp
Securities Miscellaneous		SecuritiesMiscellaneousGrp
Qualified Contrib Hist Struct		QualifiedContribHistStructGrp
Qualified Contrib Other		QualifiedContribOtherGrp
Real Estate Residential		RealEstateResidentialGrp
Real Estate Commercial		RealEstateCommercialGrp
Real Estate Other		RealEstateOtherGrp
Collectibles		CollectiblesGrp
Food Inventory		FoodInventoryGrp
Drugs And Medical Supplies		DrugsAndMedicalSuppliesGrp
Taxidermy		TaxidermyGrp
Historical Artifacts		HistoricalArtifactsGrp
Scientific Specimens		ScientificSpecimensGrp
Archaeological Artifacts		ArchaeologicalArtifactsGrp

Other Non Cash Contri Table OtherNonCashContriTableGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Desc	CHEMICALS & MATERIALS	Desc
Contribution	6	ContributionCnt
Noncash Contributions Rpt F990	$147,146	NoncashContributionsRptF990Amt
Method Of Determining Revenues	FMV	MethodOfDeterminingRevenuesTxt

Field	Value	IRS element (for citing)
Any Property That Must Be Held	false	AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts	Yes (true)	ReviewProcessUnusualNCGiftsInd
Third Parties Used	false	ThirdPartiesUsedInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (9 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART III, LINE 1 - ORGANIZATION'S MISSION:	THE NATIONAL FOUNDATION FOR CANCER RESEARCH ("NFCR") IS A LEADING PUBLIC CHARITY DEDICATED TO FUNDING CANCER RESEARCH AND PUBLIC EDUCATION RELATING TO CANCER PREVENTION, EARLIER DIAGNOSIS, BETTER TREATMENTS AND ULTIMATELY, CURES FOR CANCER. NFCR PROMOTES AND FACILITATES COLLABORATION AMONG SCIENTISTS TO ACCELERATE THE PACE OF DISCOVERY FROM BENCH TO BEDSIDE. SINCE 1973, NFCR HAS PROVIDED MORE THAN $380 MILLION IN SUPPORT OF DISCOVERY-ORIENTED CANCER RESEARCH FOCUSED ON UNDERSTANDING HOW AND WHY CELLS BECOME CANCEROUS, AND ON PUBLIC EDUCATION RELATING TO CANCER PREVENTION, DETECTION, AND TREATMENT. NFCR SCIENTISTS ARE DISCOVERING CANCER'S MOLECULAR MYSTERIES AND TRANSLATING THEIR DISCOVERIES INTO THERAPIES THAT HOLD THE HOPE FOR CURING CANCER. NFCR-FUNDED RESEARCHERS ARE MAKING PROGRESS EVERY DAY IN THEIR PURSUIT OF CANCER CURES, AND THIS IS ONLY POSSIBLE WITH THE FINANCIAL SUPPORT OF MILLIONS OF DONORS NATIONWIDE. ONE STEP AT A TIME, WE ARE GETTING CLOSER TO OUR ULTIMATE GOAL-CURING CANCER, ALL TYPES OF CANCER. FOR MORE INFORMATION, PLEASE VISIT WWW.NFCR.ORG.
PART III, LINE 4A - CANCER RESEARCH PROGRM ACCOMPLISHMENTS:	HIGHLIGHTS OF RESEARCH ACCOMPLISHMENTS ======================================== With support from our generous donors, NFCR-funded scientists have made numerous remarkable advances in the fight against cancer. Their research encompasses a wide variety of fields, many of which could ultimately lead to a cure for this deadly disease. A FEW OF THE KEY PROGRESSES ACHIEVED BY NFCR SCIENTISTS IN 2018: 20 Cancer biomarkers identification or evaluation of genetic pieces of cancers vulnerabilities that may lead doctors to earlier diagnoses and precision treatments. 8 New drug candidates and potential therapeutics identification of anticancer agents that could lead to new treatment options desperately needed by patients. 19 Cancer-Related genes and proteins discovery and further exploration of key cancer molecules which could provide new targets for drug development. NOTABLE RESEARCH HIGHLIGHTS ============================== Identifying Patients Likely to Respond to Immunotherapy -------------------------------------------------------- Immunotherapy for metastatic melanoma remarkably increases survival for some patients beyond ten years. For others, the response is minimal and ineffective treatment may continue before standard tests confirm the lack of response. Monitoring an early response to immunotherapy is a challenge. Assessing local immune response from invasive serial tumor biopsies from single metastatic sites may not represent other metastatic sites - the tumor burden - in melanoma, a cancer caused by various genes. To address this challenge, Dr. Daniel Habers team will use their previously developed liquid biopsy blood test that captures circulating tumor cells (CTCs) shed from all tumor sites and present in patients blood samples. They have discovered a signature panel of 19 RNA molecules expressed in captured melanoma CTCs that can be 'scored' to measure tumor burden in response to therapy. CTC RNA scoring blood test at 7 weeks of therapy correlated with marked improvement in survival without tumor growth. Early assessment of treatment response can guide application of immunotherapy. Moreover, CTC RNA signatures may also be identified in other cancers. Daniel Haber, M.D., Ph.D. Combination Therapy for Resistant Lung Cancer ---------------------------------------------- The cornerstone of treatment for patients with ALK-positive non-small cell lung cancer (NSCLC) is 'on target' therapies targeting the cancer-promoting ALK proteins. These therapies have dramatically improved the outlook for patients, but, eventually, almost all patients will develop resistance. their tumors will have developed 'off-target' mechanisms of resistance that activate downstream growth signaling pathways bypassing ALK. To develop a treatment for 'off-target' resistance, a panel of resistant cell lines derived from patients screened with an RNA library identified is Shp2 protein. A Shp2 inhibitor combined with on-target ALK inhibitor in patient-derived cell lines inhibited cancer cell growth. After efficacy of the two drugs is established in pre-clinical models, a first-in-man phase 1 clinical trial treating ALK-positive NSCLC patients will determine if the combination therapy can overcome resistance. Combination therapy could become a front-line therapy, and improve the chance of a durable and complete remission bringing patients one step closer to a cure. Alice T. Shaw, M.D., Ph.D. New Approaches to Treating Pancreatic Cancer --------------------------------------------- Pancreatic cancer, the 3rd leading cause of cancer death in the U.S., has a 5-year survival rate of less than 9%. One reason current treatments have limited activity is tumors are surrounded by stroma - dense fibrotic tissue of immune cells, fat cells, stem cells, fibroblasts and other cells. Stroma interacts with cancer cells, contributing to its aggressiveness and drug resistance. Also, pancreatic cancer cells themselves undergo the EMT (Epithelial-Mesenchymal Transition) process that allows the cells to metastasize and resist treatment. NFCR scientists are developing new treatments for pancreatic cancer by targeting the stroma and the EMT process. With biopsy samples from human tumors and lab models, single cell RNA sequencing identifies all RNA expressed in individual cells, revealing the distinct cell types and signaling pathways that characterize each cell population. From these results, therapies better tailored to a patients tumor are being selected to treat pancreatic cancer patients in a pilot clinical trial. EMT inhibitors are first tested in an EMT assay using zebrafish as a model, before testing in pancreatic cancer models. In this era of precision oncology, the best drugs matched to the individuals targets may further improve care of pancreatic cancer patients who have no other options. Daniel Von Hoff, M.D. Making Inroads to Defeat Metastasis ------------------------------------- At least 90% of cancer deaths are due to a tumors spread or metastasis to vital organs in our body. Dr. Danny Welch, with NFCR funds, has previously discovered eight of the 35 known metastasis suppressor genes. In metastasis, many of these genes are under-expressed and produce minimal or non-existent levels of their proteins, allowing cancer to spread. In KISS1 and BRMSI genes, his team has identified domains (small regions) in each protein that are crucial in suppressing metastasis and interacting with potential protein partners. The idea is to develop small molecules that mimic the activity of the domains and can function as a complete protein to suppress metastasis. In other research, Dr. Welch has developed a complex metastasis cancer model wherein small genetic changes (single nucleotide polymorphisms) may better explain racial disparities in tumor development, as well as better predict metastasis and patient survival. A genetic test on a patients blood sample may help doctors plan treatments more carefully. Danny R. Welch, Ph.D. Research Identifies Potential Guidance for Gastric Cancer Treatment ------------------------------------------------------------------- Researchers from Wake Forest Baptist Medical Center and Tianjin Medical University Cancer Institute and Hospital (TMUCIH) have discovered that gastric cancer tissue samples bearing mutation of a specific gene, MUC16, too are associated with higher tumor mutation loads. Also known as tumor mutation burdens, measurement of high genetic mutation rates among cancerous versus healthy tissue has increasingly been shown to correlate with effective response rates to immunotherapy. The knowledge could bode positively for patients with the biomarker present. Tumors with higher tumor mutation loads tend to be more responsive to immunotherapy. The authors stress the implications that this and other proven biomarkers have on the ability of oncologists to design cancer treatments most likely to succeed. Findings from this study, for example, could serve to open immunotherapy options for up to 38% of gastric cancer patients. Wei Zhang, Ph.D. Attacking Metastatic Tumors in the Brain ------------------------------------------ A discovery by NFCR scientists and collaborators could be very important for patients whose cancers have spread to the brain. About 25% of all breast cancers have an excess of Human Epidermal Growth Factor Receptor 2 (known as HER 2positive or HER2+) which spreads more quickly than other types of breast cancer. HER2+ targeted therapies treat HER2+ breast cancer and patients are in remission for years or longer. However, up to 50% of these patients receiving these targeted therapies eventually develop brain metastases, which are inevitably fatal. Research with tumor models and human cancer samples has determined breast-cancer-associated brain lesions overexpress another related factor, HER3, and that inhibiting HER3 could help overcome treatment resistance. Importantly, HER2 targeted therapy combined with inhibitors to HER3 significantly slowed brain metastatic tumor growth and improved survival in tumor models. This discovery could have a substantial impact on the future development of therapeutic strategies and ultimately, patient survival from this deadly disease. Moreover, since HER3 expression is associated with treatment resistance in several types of cancer, this discovery could potentially benefit a much broader group of patients. Rakesh Jain, Ph.D.
PART III, LINE 4B - CANCER PREVENTION EDUCATION TO THE PUBLIC:	NFCR provides the public with free publications containing valuable information on the most up-to-date cancer preventive measures, treatment options, and diagnostic tools. Our powerful message mailed to tens of millions of families and reaching tens of thousands of individuals through our social media channels (twitter and facebook) and through our blogs, helps to assure that fewer of todays healthy individuals will get cancer and more of todays cancer patients will become tomorrows cancer survivors. Our public education materials include early cancer detection guide, a Childhood Cancer Chart, cancer prevention kits, recipes for healthy living, electronic and printed newsletters, the latest cancer headlines, and in-depth online cancer information.
PART VI, SECTION A, LINE 2 - DIRECTORS/OFFICERS WITH FAMILY RELATIONSHIPS:	FRANKLIN SALISBURY, CEO, AND SUJUAN BA, PRESIDENT/COO, ARE HUSBAND AND WIFE.
PART VI, SECTION B, LINE 11B - REVIEW PROCESS OF FORM 990:	THE NATIONAL FOUNDATION FOR CANCER RESEARCH'S PROCESS FOR REVIEWING THE FORM 990. ======================================================================== 1. FORM 990 WILL BE PREPARED AFTER ANNUAL AUDIT IS DONE. 2. THE FIRST DRAFT WILL BE REVIEWED BY THE CHIEF OPERATING OFFICER AND THE CHIEF FINANCIAL OFFICER. 3. AFTER RESOLVING ANY QUESTIONS OR UPDATES, THE REVISED DRAFT WILL BE SENT TO BOARD MEMBERS, PREFERABLY ELECTRONICALLY FOR THEIR REVIEW AND COMMENTS. 4. THE BOARD MEMBER'S COMMENTS, IF ANY, WILL BE INCORPORATED IN THE FINAL RETURN. 5. THE RETURN WILL BE FILED WITH THE IRS PRIOR TO THE DESIGNATED DUE DATE OR EXTENDED DUE DATE. 6. THE STATE VERSION WILL BE PROVIDED TO STATES FOR REGISTRATION RENEWALS AND THE PUBLIC PORTIONS OF THE RETURN WILL BE POSTED ON THE FOUNDATION'S WEBSITE. 7. IN THE OCCASION THAT THERE IS INSUFFIENT TIME PRIOR TO FILING FORM 990 TO SHARE IT WITH THE BOARD, OR THERE IS ABSENSE OF AN OPPORTUNITY FOR ANY MEANINGFUL REVIEW OF FORM 990 BY THE BOARD PRIOR TO THE FILINGS DEALINE, AN ELECTRONIC VERSION OF THE FILED RETURN WILL BE AVAILABLE FOR BOARD MEMEBER'S REVIEW AND COMMENTS AFTER SUBMISSION OF RETURN TO IRS. AN AMENDED RETURN IF NECESSARY, WILL BE FILED.
PART VI, SECTION B, LINE 12C - CONFLICT OF INTEREST POLICY COMPLIANCE:	EACH DIRECTOR, PRIOR TO TAKING HIS/HER POSITION ON THE BOARD, AND ALL PRESENT DIRECTORS SHALL SUBMIT IN WRITING TO THE CHAIRMAN OF THE BOARD A LIST OF ALL BUSINESSES OR OTHER ORGANIZATIONS OF WHICH HE/SHE IS AN OFFICER, DIRECTOR, TRUSTEE, MEMBER, OWNER SHAREHOLDER, EMPLOYEE OR AGENT, WITH WHICH THE FOUNDATION HAS, OR MIGHT REASONABLE IN THE FUTURE ENTER INTO, A RELATIONSHIP OR A TRANSACTION IN WHICH THE DIRECTOR WOULD HAVE CONFLICTING INTEREST ANNUALLY.
PART VI, SECTION B, LINE 15A/15B - OFFICERS COMPENSATION:	ON AN ANNUAL BASIS, THE BOARD WILL PERFORM A THOROUGH REVIEW TO DETERMINE SUITABLE COMPENSATION. THIS PROCESS INCLUDES ALL OF THE FOLLOWING THREE ELEMENTS. ======================================================================= 1. REVIEW AND APPROVAL BY BOARD OF DIRECTORS: THE COMPENSATION OF EACH OFFICER IS REVIEWED AND APPROVED BY THE BOARD OF DIRECTORS, PROVIDED THAT PERSONS WITH CONFLICTS OF INTEREST WITH RESPECT TO THE COMPENSATION ARRANGEMENT AT ISSUE ARE NOT INVOLVED IN THIS REVIEW AND APPROVAL. EACH OFFICER'S PERFORMANCE IS EVALUATED BASED ON HIS OR HER JOB RESPONSIBILITIES, AND INTERNAL AND EXTERNAL GOALS SET IN THE PREVIOUS YEAR. 2. REVIEW OF "COMPARABLE COMPENSATION" DATA: THE COMPENSATION OF EACH OFFICER IS REVIEWED AND APPROVED USING DATA AS TO COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS. COMPARABLE DATA ARE COMPILED BY THE FOUNDATION'S CHIEF FINANCIAL OFFICER AND/OR BY OUTSIDE COMPENSATION CONSULTANTS. COMPARABILITY DATA CAN INCLUDE COMPENSATION DATA FROM IRS FORM 990'S OF SIMILAR ORGANIZATIONS, PUBLISHED COMPENSATION SURVEYS, STUDIES AND GUIDES, AND OTHER SOURCES DEEMED APPROPRIATE AT THE TIME. 3. DOCUMENTATION AND RECORDKEEEPING: THERE IS CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING WITH RESPECT TO THE DELIBERATIONS AND DECISIONS REGARDING THE COMPENSATION AGREEMENT. THE RECORD IS KEPT BY THE SECRETARY OF THE FOUNDATION.
PART VI, SECTION C, LINE19-AVAILABILTY OF DOCUMENTS, POLICIES, AND F/S:	THE FOUNDATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. THE FINANCIAL STATEMENTS ARE ALSO AVAILABLE ON THE FOUNDATION'S WEBSITE.
PART IX, LINE 26, JOINT COSTS ALLOCATION:	NFCR IS COMMITTED TO EFFICIENCY AND TRANSPARENCY. FOR MORE THAN 40 YEARS, NFCR HAS BEEN COMMUNICATING WITH SUPPORTERS, DONORS, AND PROSPECTIVE DONORS BY EMAIL, POSTAL EMAIL, PHONE AND OTHER MEANS, BOTH TO REQUEST CONTRIBUTIONS AND TO EDUCATE THE PUBLIC, THEREBY UPHOLDING NFCR'S MISSION STATEMENT (TO SUPPORT CANCER RESEARCH AND PUBLIC EDUCATION RELATING TO THE PREVENTION, EARLY DIAGNOSIS, BETTER TREATMENTS AND ULTIMATELY, A CURE FOR CANCER). THESE FREE PUBLICATIONS ARE SENT TO TENS OF MILLIONS OF FAMILIES AND INCLUDE MATERIALS SUCH AS EARLY DETECTION GUIDES, CHILDHOOD CANCER CHARTS, CANCER PREVENTION KITS AND RECIPES FOR HEALTHY LIVING. AS A RESULT, IN ACCORDANCE WITH THE FINANCIAL ACCOUNTING STANDARDS BOARD (FASB) GUIDELINES SOP 98-2 (ASC 958-720), WE ALLOCATE A PORTION OF OUR DIRECT MAIL COST TO PROGRAM SERVICES AND TO FUNDRAISING.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (2 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Exempt Code SectionExemptCodeSectionTxt	Public Charity StatusPublicCharityStatusTxt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt	Controlled OrganizationControlledOrganizationInd
DARWIN FOUNDATION
5515 SECURITY LANE SUITE 1105	ROCKVILLE	MD	20852	371473821	CANCER RESEAR	DC	501(C)3	509(A)(3)	NFCR	Yes (true)
RESEARCH FOR A CURE
5515 SECURITY LANE SUITE 1105	ROCKVILLE	MD	20852	010744146	CANCER RESEAR	DC	501(C)3	509(A)(3)	NFCR	Yes (true)

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	false	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	false	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	false	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	false	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	false	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	false	DivRelatedOrganizationInd
Asset Sale To Other Org	false	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	false	AssetPurchaseFromOtherOrgInd
Asset Exchange	false	AssetExchangeInd
Rental Of Facilities To Oth Org	false	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	false	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	false	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	false	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	Yes (true)	SharingOfFacilitiesInd
Paid Employees Sharing	Yes (true)	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	false	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	false	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	Yes (true)	TransferToOtherOrgInd
Transfer From Other Org	false	TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp

Other Organization Name OtherOrganizationName

Field	Value	IRS element (for citing)
Business Name Line1	DARWIN FOUNDATION	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Transaction Type	R	TransactionTypeTxt
Involved	$100,000	InvolvedAmt
Method Of Amount Determination	CASH	MethodOfAmountDeterminationTxt